Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation. Article
Overview
publication date
- December 1, 2004
published in
Research
keywords
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Piperazines
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Protein Kinase Inhibitors
- Pyrimidines
- Stem Cell Transplantation
Identity
Scopus Document Identifier
- 10344241010
PubMed ID
- 15570257
Additional Document Info
has global citation frequency
volume
- 10
issue
- 12